ÂÜÀòÂÒÂ×

Emily O'Connor is an accomplished leader in commercial strategy and operations, currently serving as the Head of Commercial Strategy & Operations and Chief of Staff to the Chief Commercial Officer at Gilead Sciences since January 2021. With extensive experience in hematology and cardiovascular marketing, Emily previously held positions such as US & Global Brand Lead and Executive Director for hematology at Gilead, and US Brand Lead and Executive Director for cardiovascular marketing at Amgen, where significant achievements included developing strategies for drug launches and establishing digital capabilities. Earlier roles at Amgen encompassed impactful market access initiatives and sales responsibilities in oncology, while consulting at Trinity Partners enhanced Emily's strategic acumen in the life sciences sector. Emily holds an MBA in Healthcare and Pharmaceutical Management from Columbia Business School and a BA in English and Political Science from Middlebury College.